Core Viewpoint - The legal opinion confirms that the procedures for convening and holding the third extraordinary general meeting of Tianjin Tianshili Pharmaceutical Group Co., Ltd. are in compliance with relevant laws and regulations, and the voting results are valid [1][2][4]. Group 1: Meeting Procedures - The notice for the meeting was issued on April 29, 2025, detailing the time, location, and agenda [2]. - The meeting was held on May 14, 2025, using a combination of on-site and online voting methods [2][3]. - The voting period for online participation was specified, and the procedures followed were in accordance with legal and regulatory requirements [2][3]. Group 2: Attendance and Qualifications - The meeting was attended by shareholders and their proxies, with verification of their identities conducted by the Shanghai Stock Exchange [3]. - The board of directors served as the convener of the meeting, and the qualifications of attendees were deemed valid [3]. Group 3: Voting Procedures and Results - Voting was conducted through both on-site and online methods, with results compiled after the voting concluded [4]. - The first resolution, requiring a two-thirds majority, was passed, while the second resolution, needing a simple majority, was also approved [4]. - The voting process and results were confirmed to be in compliance with legal and regulatory standards [4].
天士力: 内蒙古建中律师事务所关于天士力医药集团股份有限公司2025年第三次临时股东大会的法律意见书